Effectiveness of mouse minute virus inactivation by high temperature short time treatment technology: A statistical assessment

Viral contamination of mammalian cell cultures in GMP manufacturing facility represents a serious safety threat to biopharmaceutical industry. Such adverse events usually require facility shutdown for cleaning/decontamination, and thus result in significant loss of production and/or delay of product...

Full description

Saved in:
Bibliographic Details
Published in:Biologicals 2011-11, Vol.39 (6), p.438-443
Main Authors: Murphy, Marie, Quesada, Guillermo Miro, Chen, Dayue
Format: Article
Language:English
Subjects:
Algorithms
Animals
biopharmaceutical industry
cell culture
Cell Line
cleaning
culture media
Culture Media - analysis
Culture medium
decontamination
Disinfection - methods
Drug Contamination - prevention & control
High temperature short time
Hot Temperature
Humans
Kinetics
manufacturing
Mice
Minute Virus of Mice - physiology
Mouse minute virus
product development
Reproducibility of Results
risk
Technology, Pharmaceutical - methods
temperature
Time Factors
Viral contamination
Virus Inactivation
Virus Replication - physiology
viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Viral contamination of mammalian cell cultures in GMP manufacturing facility represents a serious safety threat to biopharmaceutical industry. Such adverse events usually require facility shutdown for cleaning/decontamination, and thus result in significant loss of production and/or delay of product development. High temperature short time (HTST) treatment of culture media has been considered as an effective method to protect GMP facilities from viral contaminations. Log reduction factor (LRF) has been commonly used to measure the effectiveness of HTST treatment for viral inactivation. However, in order to prevent viral contaminations, HTST treatment must inactivate all infectious viruses (100%) in the medium batch since a single virus is sufficient to cause contamination. Therefore, LRF may not be the most appropriate indicator for measuring the effectiveness of HTST in preventing viral contaminations. We report here the use of the probability to achieve complete (100%) virus inactivation to assess the effectiveness of HTST treatment. By using mouse minute virus (MMV) as a model virus, we have demonstrated that the effectiveness of HTST treatment highly depends upon the level of viral contaminants in addition to treatment temperature and duration. We believe that the statistical method described in this report can provide more accurate information about the power and potential limitation of technologies such as HTST in our shared quest to mitigate the risk of viral contamination in manufacturing facilities.
ISSN:1045-1056
1095-8320
DOI:10.1016/j.biologicals.2011.07.001